Published on: 9 July 2019 Roche presents a broad range of data for Hemlibra demonstrating continued benefits for people with haemophilia A at the ISTH 2019 Congress more
Published on: 3 July 2019 Roche announces positive results for first global phase III study investigating one-dose Xofluza (baloxavir marboxil) in children with flu more
Published on: 28 June 2019 CHMP recommends EU approval of Roche’s Tecentriq in combination with Abraxane as an initial treatment for people with PD-L1-positive, metastatic triple-negative breast cancer more
25July Roche Half Year Results 2019 Live video webcast (CEST) Basel, Switzerland more add to calendar
Latest annual report Annual Report 2018 Highlights How digital innovation increases patient benefit in the future more Annual Report 18 Finance Report 18 Roche in Brief 18 Roche Fact Sheet
Message from our CEO “The foundation of our success is and will remain our clear focus on innovation.”
